GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

Similar documents
Staging and Treatment Update for Gynecologic Malignancies

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

What is endometrial cancer?

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

OVARIAN CARCINOMA Immune Therapy. Antibodies to CA-125 (Ovarex) Vaccine therapy

Guidelines for Assigning Summary Stage 2000

Endometrial Cancer. Incidence. Types 3/25/2019

Approach to imaging of the ovaries

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

Stage 3 ovarian cancer survival rate

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

Stage 3 ovarian cancer survival rate

Janjira Petsuksiri, M.D

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Work up of a Pelvic Mass

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

CA125 in the diagnosis of ovarian cancer: the art in medicine

One of the commonest gynecological cancers,especially in white Americans.

Cervical cancer presentation

Case Scenario 1. History

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22

Carcinoma of the Fallopian Tube

CASE STUDY. Presented by: Jessica Pizzo. CFCC Sonography student Class of 2018

Birthday: 1952/07/31 Date of admission:1999/12/30 Age:48 y/o Past medication:esrd under regular HD for 5+ years; denied DM and HTN

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Patient Information. Age: 8 y/o Sex: Female. Date of Admission: Date of Discharge:

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Cervical Cancer: 2018 FIGO Staging

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Ovarian Lesion Benign vs Malignant?

بسم هللا الرحمن الرحيم. Prof soha Talaat

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Interactive Staging Bee

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Bilateral Primary Fallopian Tube Carcinoma: Findings on Sequential MRI

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Ovarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Vaginal intraepithelial neoplasia

Gynaecological Oncology Cases

H&E, IHC anti- Cytokeratin


Early View Article: Online published version of an accepted article before publication in the final form.

JMSCR Vol 05 Issue 06 Page June 2017

What You Need to Know About Ovarian Cancer

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Basic Data. Birthday: Gender:Female Admission date:

The many faces of Endometriosis

Category Term Definition Comments 1 Major Categories 1a

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

What is ovarian cancer?

The Human Body: An Overview of Anatomy. Anatomy. Physiology. Anatomy - Study of internal and external body structures

NAACCR Webinar Series /7/17

Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix.

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS

ADENOMYOSIS CHRONIC PELVIC PAIN IN WOMEN IMAGING CHRONIC PELVIC PAIN IN WOMEN CHRONIC PELVIC PAIN IN WOMEN ADENOMYOSIS: PATHOLOGY ADENOMYOSIS

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive

UICC TNM 8 th Edition Errata

Case Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor

X-Plain Ovarian Cancer Reference Summary

ENDOMETRIOSIS AS A COMMON CAUSE OF PELVIC PAIN

Endometriosis - MRI findings with anatomic-pathologic correlation

In the name ofgod. Abdomen 3. Dr. Zahiri

Recurrent Ovarian Cancer: Spectrum of Imaging Findings

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis

Personal data. Age : 63 Gender : male

Imaging in gastric cancer

Pre-operative assessment of patients for cytoreduction and HIPEC

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

Hitting the High Points Gynecologic Oncology Review

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION CYTOPATHOLOGY Monday, April 26, 2013 FACULTY COPY

Ovarian Cancer. What you should know. making cancer less frightening by enlightening

Gastric (Stomach) Cancer

Pelvic Pain. What you need to know. 139 Dumaresq Street Campbelltown Phone Fax

3 cell types in the normal ovary

Adnexal Masses and Problem Solving Pelvic MRI

ARROCase: Locally Advanced Endometrial Cancer

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

Transcription:

GENERAL DATA Sex : female Age : 40 years old Marriage status : married

CHIEF COMPLAINT Bilateral ovarian tumors discovered by sonography accidentally

PRESENT ILLNESS 2003-06-26 :bilateral ovarian tumors were noted accidentally by routine Pap smear 2003-06-27 : Dr. 劉偉民 OPD Sonography Pelvic CT No dysmenorrhea, no abnormal vaginal bleeding, no body weight loss, no abdominal discomfort, no urinary incontinence, no frequency or tenesmus 2003-06-28 : panendoscope

PAST HISTORY Medical history : nil Surgical history : Hemorrhoid : 1997

PERSONAL HISTORY HTN : (-) DM : (-) Smoking : denied Drinking : denied Allergy : not known No other systemic disease

PHYSICAL EXAMINATION No positive finding

2003-06-29 : WBC : 3.62 RBC : 3.88 HGB : 11.9 HCT : 33.2 MPV : 6.6 2003-06-29 : U/A LAB DATA OCCULT BLOOD : 2+ RBC : 5-8, WBC : 10-12, Epithel : 8-10

CA19-9 LAB DATA 2003-06-27 : 446 u/ml 2003-07-18 : 30.4 u/ml

Chest X ray KUB Sonography panendoscope Pelvic CT IMAGE STUDY

CHEST X-RAY Normal heart size No abnormal radiopaque densities at bil lung No widening of mediastinum Relatively clear bil. C-P angle

KUB Nonspecific gaseous pattern of bowel Fecal material distension of abdominal-pelvis Evidence of scoliosis Well defined of bil psoas muscle

COMPUTOR TOMOGRAPHY 2003-06-27 pelvis CT Pre-enhanced There are multiple lesions composed of solid and cysts over bilateral adenxa

COMPUTOR TOMOGRAPHY Post enhanced There are separate heterogeneous contrast enhancing lesions involving the bilateral adenxa. Mass Right : 5*8.4*5 cm Left : 5.8*4.1*4 cm

COMPUTOR TOMOGRAPHY Post-enhanced

COMPUTOR TOMOGRAPHY Post-enhanced There are several slight enhancing nodules at the segment VII and VIII of the liver

COMPUTOR TOMOGRAPHY Post-enhanced There is a 2.3cm*1.6cm nodule extending from the peritoneum, right anterior of the liver

2003-06-27 Finding : SONOGRAPHY Right ovarian texture : with cysts Left ovarian texture : with mass Cul-De-Sac : with fluid Endometrium : thickness 9 mm Impression : Endometrioma Benign ovarian tumor

2003-06-30 Finding : ENDOSCOPE Esophagus : negative Stomach : some erosions at body and atrum Duodenum : negative up to 2 nd portion Impression : Stomach : erosion Superficial gastritis

DIFFERENTIAL DIAGNOSIS Ovarian cyst Tuboovarian abscess Ovarian tumor

OVARIAN CYST Functional cysts are the most common ovarian masses in ovulatory women. They are divided into follicular, corpus luteum, and theca-lutein cysts. Follicular cysts are the most common of the three. They are usually asymptomatic and found incidentally on physical examination or ultrasonography Sonographically, they are usually thin-walled, anechoic structures with a well-defined posterior wall.

TUBO-OVARIAN ABSCESS occur with prior or concomitant pelvic inflammatory disease Symptoms : pelvic pain, fever, vaginal discharge, and abnormal bleeding, along with findings of an exquisitely tender pelvic mass. Shrinkage and resolution of the mass with intense antibiotic treatment confirm the clinical impression Contrast computed tomography scan : cystic masses with irregular, contrast-enhancing borders or Complex cystic mass with air-fluid level

IMPRESSION Bilateral ovarian malignancy Hepatic metastasis Peritoneum metastasis

OPERATION 2003-07-01 Pre-op diagnosis : ovarian cancer Post-op diagnosis : ovarian cancer Method : optimal debulking surgery Washing cytology TAH (total abdominal hysterectomy) BSO (bilateral salpingo-ovariotomy) Omentectomy +appendectomy Lymph node dissection : bilateral pelvis + para-aorta CUSA for residual tumor

OP finding: OPERATION Diaphragm : miliary tumors seeding+2cm mass peri-t colon : a 5 cm mass Omentum : an obvious mass+multiple seeding Peritoneum : multiple seeding Bilateral ovarian : masses Cul-de-sac : 5cm mass Urinary bladder : adhesion mass with uterus Pelvic lymph node : no obvious enlargement

PATHOLOGICAL FINDING Bilateral ovaries : serous papillary carcinoma Uterus and appendix : nests of serous papillary carcinoma Fallopian,urinary bladder,mesentery, and omentum : be involved by the tumor Cervix : mild chronic cervicitis without tumor involvment Lymph node : metastatic carcinima Left external iliac : 07 Right external iliac : 0/5 Left obturator : ½ Paraaortic : ¼ Ascites : adenocarcinoma

DISCUSSION -ovarian carcinoma commonest cause of death from gynecologic malignancy, and is the fifth commonest cause of cancer deaths in women The lifetime risk of ovarian cancer in women is 1.5%, and the overall mortality is approximately 60%

DISCUSSION -ovarian carcinoma Symptom There are no obvious symptoms until the disease has advanced. Vague but persistent gastrointestinal complaints such as gas, nausea, indigestion. Frequency and/or urgency of urination. Any unexplained change in bowel habits. Abnormal postmenopausal bleeding. Weight gain or loss. Abdominal swelling and/or pain; bloating and/or a feeling of fullness. Pain during intercourse.

DISCUSSION -ovarian carcinoma FIGO staging system for ovarian cancer Based on the presence of surface tumor, tumor rupture, ascites containing malignant cells, or positive washings. Stage I : Grossly confined to one or both ovaries. IA: Intracapsular and unilateral IB: Intracapsular and bilateral IC: Actual or potential microscopic peritoneal contamination a Stage II :Local extension; grossly confined to the true pelvis IIA: Involvement of Fallopian tubes or uterus IIB: Involvement of other pelvic tissues, eg, sigmoid, pelvic implants IIC: Actual or potential microscopic peritoneal contamination a

DISCUSSION -ovarian carcinoma Stage III :Nodal metastases, or peritoneal implants outside the pelvis. IIIA: Microscopic abdominal implants IIIB: < 2 cm abdominal implants IIIC: > 2 cm abdominal implants or positive nodes Stage IV : Distant spread, for example malignant pleural effusion, intrahepatic metastases

Approximately 90% of ovarian cancers are of epithelial origin. Subtyped as serous (50%), mucinous (20%), endometrioid (20%), clear cell (10%), or undifferentiated (1%). Epithelial cancers are typically cystic and have a propensity to spread within the peritoneal cavity.

serous papillary type It accounts for approximately 10% of all serous ovarian tumors, and carries a worse prognosis. there is usually extensive peritoneal spread present by the time of diagnosis. some believe the tumor arises from the peritoneal surface, and spreads secondarily to the ovary. Common clinical features : abdominal pain and distension, a pelvic mass and ascites. Treatment : as for ovarian cancer, including surgery and chemotherapy. Imaging findings include normal or minimally enlarged ovaries, ascites and small peritoneal nodules. Lymphadenopathy is uncommon.

Axial contrast-enhanced CT section through the pelvis showing the ovaries encased by irregular nodules of serous papillary carcinoma (arrow).

Axial T2-weighted MRI section at the corresponding level in the same patient, demonstrating similar findings. Preservation of normal ovarian architecture within the encasing tumour is evident (arrows).

CA 125 TUMOR MAKER True Positive: Approximately 80 percent of women who have ovarian cancer will have an elevated CA- 125 in the serum portion of their blood at the time of diagnosis. False positive: makes it inadequate for use by itself for screening of high-risk or healthy women. Premenopausal women are more likely than postmenopausal women to receive a "false positive" CA-125. It should be supplemented with transvaginal sonography and a rectovaginal pelvic exam all done at the same time.

Frequency of distant metastases in ovarian cancer Liver : 45 48% Lung : 34 39% Pleura : 25% Adrenal glands :15-21% Spleen : 15 20% Bone and bone marrow: 11% Kidney : 7 10% Skin and subcutaneous tissues : 5% Brain : 3 6%

Image study DISCUSSION -ovarian carcinoma Ultrasound : the primary modality used for the detection and characterization of adnexal masses CT : the primary modality used for staging of ovarian cancer MRI :useful in the characterization of ovarian masses and for the elucidation of certain equivocal CT findings

Typical CT findings DISCUSSION -ovarian carcinoma The majority of malignant epithelial tumors appear as cystic masses lateral to the uterus. Ovarian masses may also be seen in the midline above the bladder or anterior to the rectum frequently bilateral Features that suggest malignancy in a cyst are thick (>3 mm) walls or septa, nodules, vegetations, or papillary projections Calcification suggests a serous tumor, but only 12% of serous tumors have calcification that is visible at CT

the commonly seen sites of peritoneal metastases in ovarian cancer : Pouch of Douglas Surface of the small and large bowel Greater omentum Surface of the liver (perihepatic implants) Subphrenic space (right greater than left)

The ovarian lymphatic vessels are another important route of metastatic spread The main pathway ascends with the ovarian vessels to the retroperitoneal nodes of the upper abdomen. The second pathway passes laterally in the broad ligament to reach the internal iliac and obturator nodes in the pelvic side wall. The third group passes with the round ligament to the external iliac and inguinal nodes, and explains the occasional spread of ovarian cancer to the groin

SUMMARY Previous studies examining the accuracy of CT in the diagnosis of peritoneal metastases in ovarian cancer have reported a sensitivity of 63% to 79% and a specificity of 100%